account_balance
Investment manager · 13F filer · SEC CIK 1858703
Blue Owl Capital Holdings LP
Reported value$658Mas of Jun 30, 2026
Positions71 18 new, 22 sold out
Top 10 weight79.3%SPCX alone is 36%
FiledAug 1142 days after quarter end
Portfolio · as of Jun 30, 2026
Where the money is
New or addedTrimmedHeld
SPCXSpace Exploration Techn Corp
36.3%New
AKTSAktis Oncology Inc
15.0%Trimmed −3%
CGEMCullinan Therapeutics Inc
4.3%Trimmed −19%
LRMRLarimar Therapeutics Inc
4.2%Added +29%
NCDLNuveen Churchill Direct Lend
4.0%
MPLTMaplight Therapeutics Inc
4.0%Trimmed −27%
COFCapital One Finl Corp
3.7%New
OBDCBlue Owl Capital Corporation
3.4%
FISN2.2%DELL2.2%HLLYHolley Inc
1.7%Added +3%
EYPTEyepoint Inc
1.7%Trimmed −16%
SPCXSpace Exploration Techn Corp
36.3%New
AKTS15.0%CGEM4.3%LRMR4.2%NCDL4.0%MPLT4.0%COF3.7%OBDC3.4%FISNDELLHLLYEYPTBoxes show the top 12 stocks, sized against each other. The bar above shows how much of the fund they are. 13F only covers US-listed stocks, so foreign holdings and short positions are missing.
Show the top 12 as a list
SPCX Space Exploration Techn Corp 36.3% NewAKTS Aktis Oncology Inc 15.0% Trimmed −3%CGEM Cullinan Therapeutics Inc 4.3% Trimmed −19%LRMR Larimar Therapeutics Inc 4.2% Added +29%NCDL Nuveen Churchill Direct Lend 4.0% HeldMPLT Maplight Therapeutics Inc 4.0% Trimmed −27%COF Capital One Finl Corp 3.7% NewOBDC Blue Owl Capital Corporation 3.4% HeldFISN Deep Fission Inc 2.2% NewDELL Dell Technologies Inc 2.2% Added +137%HLLY Holley Inc 1.7% Added +3%EYPT Eyepoint Inc 1.7% Trimmed −16%
What changed